Cybin (HELP) Assets Average (2021 - 2025)
Cybin (HELP) reported Assets Average of $180.2 million for Q2 2025, down 16.61% on a YoY basis from $216.1 million in Q2 2024, and little changed quarter-over-quarter from $180.9 million in Q1 2025.
Cybin (HELP) Assets Average (2021 - 2025) Analysis & Trends
Cybin has reported Assets Average for 5 years, with the latest figure at $180.2 million in Q2 2025.
- For the quarter ending Q2 2025, Assets Average fell 16.61% year-over-year to $180.2 million; the trailing twelve-month figure through Jun 2025 stood at $180.2 million (down 16.61% YoY), and the FY2025 full-year result was $205.1 million, up 58.45% from the prior year.
- Assets Average for Q2 2025 stood at $180.2 million, roughly flat from $180.9 million in the prior quarter.
- The five-year high for Assets Average was $216.1 million in Q2 2024, with the low at $39.3 million in Q1 2023.
- Historically, Assets Average has averaged $114.5 million across 5 years, with a median of $77.6 million in 2021.
- Annual changes were most pronounced in 2022 — Assets Average plunged 38.66% — and 2024, when it soared 373.23%.
- Cybin's Assets Average stood at $79.6 million in 2021, then tumbled by 38.66% to $48.9 million in 2022, then surged by 41.52% to $69.1 million in 2023, then jumped by 170.37% to $186.9 million in 2024, then decreased by 3.58% to $180.2 million in 2025.
- The last three Assets Average figures came in at $180.2 million (Q2 2025), $180.9 million (Q1 2025), and $186.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | 180.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 180.24 Mn |
| Mar 31, 2025 | 180.87 Mn |
| Dec 31, 2024 | 186.92 Mn |
| Sep 30, 2024 | 200.23 Mn |
| Jun 30, 2024 | 216.13 Mn |
| Mar 31, 2024 | 159.71 Mn |
| Dec 31, 2023 | 69.14 Mn |
| Sep 30, 2023 | 50.26 Mn |
| Jun 30, 2023 | 45.67 Mn |
| Feb 28, 2023 | 39.26 Mn |
| Dec 31, 2022 | 48.85 Mn |
| Dec 31, 2021 | 79.64 Mn |
| Sep 30, 2021 | 75.59 Mn |
| Jun 30, 2021 | 70.08 Mn |